The prognosis of patients having received optimal therapy for nonvariceal upper gastrointestinal bleeding might be worse in daily practice than in randomized clinical trials
Authors:
- Audrey WeberAWAudrey Weber
- Stéphane KochSKStéphane Koch
- Nicolas FestouNFNicolas Festou
- Anne Claire Dupont-GossardADAnne Claire Dupont-Gossard
- Jean Paul CervoniJCJean Paul Cervoni
- Elisabeth MonnetEMElisabeth Monnet
- Marc BardouMBMarc Bardou
- Franck CarbonnelFCFranck Carbonnel
- 1 March 2010
- journal article
- research article
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 22 (3) , 361-367
Abstract
Combination of endoscopic haemostatic and high-dose intravenous proton-pump inhibitors is considered to be the standard care for patients with acute peptic ulcer bleeding. This study assessed predictive factors of rebleeding and death in unselected patients presented to our hospital. Consecutive patients with nonmalignant bleeding ulcers and stigmata of recent haemorrhage who received optimal treatment, between 22 August 2003 and 15 October 2007, were studied retrospectively. Among 140 included patients, 45 (32%) rebled and 30 received another haemostatic endoscopy, which was successful in 20 cases. In multivariate analysis, the only significant predictive factor of rebleeding was duodenal site of the ulcer [adjusted odds ratio (OR): 2.75; 95% confidence interval (CI): 1.28–6.19]. In-hospital death occurred in 27 (19%) patients; with five deaths related to uncontrolled or recurrent bleeding. In multivariate analysis, predictors of in-hospital mortality were rebleeding (adjusted OR: 3.28; 95% CI: 1.17–9.16), a Rockall score higher than 6 (adjusted OR: 9.12; 95% CI: 2.57–44.29) and bleeding occurring in the intensive care unit (adjusted OR: 15.68; 95% CI: 4.41–55.82). In unselected patients, rebleeding and mortality rates are substantially higher than those found in prospective randomized clinical trials. Intensive care unit stay is an important predictive factor of hospital mortality and should be considered in further therapeutic trials in ulcer bleeding.Keywords
This publication has 31 references indexed in Scilit:
- Comparison of hemostatic efficacy for epinephrine injection alone and injection combined with hemoclip therapy in treating high-risk bleeding ulcersGastrointestinal Endoscopy, 2006
- A prospective, randomized trial comparing mechanical methods of hemostasis plus epinephrine injection to epinephrine injection alone for bleeding peptic ulcerGastrointestinal Endoscopy, 2004
- The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life SettingAmerican Journal of Gastroenterology, 2004
- A randomized trial comparing injection therapy with hemoclip and with injection combined with hemoclip for bleeding ulcersGastrointestinal Endoscopy, 2002
- Comparison of adrenaline injection and bipolar electrocoagulation for the arrest of peptic ulcer bleedingGut, 1999
- Comparison of the hemostatic efficacy of the endoscopic hemoclip method with hypertonic saline–epinephrine injection and a combination of the two for the management of bleeding peptic ulcersGastrointestinal Endoscopy, 1999
- Randomised comparison between adrenaline injection alone and adrenaline injection plus heat probe treatment for actively bleeding ulcersBMJ, 1997
- A prospective randomized trial of heater probe thermocoagulation versus injection therapy in peptic ulcer hemorrhageGastrointestinal Endoscopy, 1996
- Injection or heat probe for bleeding ulcerGastroenterology, 1991
- Endoscopic injection of adrenaline for actively bleeding ulcers: a randomised trialBMJ, 1988